RAYMOND JAMES & ASSOCIATES - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$303,000
+19.8%
24,117
+11.1%
0.00%
Q4 2021$253,00021,6990.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BVF INC/IL 5,597,065$72,510,00015.06%
SOUND ENERGY PARTNERS, INC. 400,566$5,189,0004.02%
SECTOR GAMMA AS 1,138,291$14,747,0003.45%
Orbimed Advisors 12,012,100$155,617,0001.62%
SHAPIRO ROBERT N 485,974$6,296,0001.20%
Broderick Brian C 166,345$2,156,0000.96%
Hall Kathryn A. 193,588$2,508,0000.65%
Tekla Capital Management LLC 768,050$9,950,0000.47%
PARADIGM ASSET MANAGEMENT CO LLC 180,800$2,342,264,0000.33%
BOURGEON CAPITAL MANAGEMENT LLC 42,800$554,0000.32%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders